Clinical Trials List
2022-01-01 - 2025-12-31
Phase II
Recruiting4
Terminated2
ICD-10B18.1
Chronic viral hepatitis B without delta-agent
ICD-9070.32
Viral hepatitis B without mention of hepatic coma, chronic, without mention of hepatitis delta
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Hsueh-Chou Lai NA
- Hung-Wei Wang NA
- Wei-Fan Hsu NA
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chao-Wei Hsu NA
- 鄭雅婷 NA
- Yi-Chung Hsieh NA
- I-Shyan Sheen NA
- Chien-Hao Huang NA
- Rong-Nan Chien NA
- Chun-Yen Lin NA
- 滕威 NA
- Yi-Cheng Chen NA
- 戴達英 NA
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chung-Feng Huang NA
- 梁博程 NA
- Ming-Lun Yeh NA
- Jee-Fu Huang NA
- Chia-Yen Dai NA
- Ming-Lung Yu NA
- 黃駿逸 NA
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hsin-Yu Kuo NA
- Chiu Hung Chiu NA
- 邱彥程 NA
- 吳毅晉 NA
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- TENG-YU LEE NA
- Sheng-Shun Yang Digestive System Department
- 呂宜達 NA
- 李少武 NA
- 黃儀倢 NA
- 林宛姿 NA
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20-40 participants
-
Global
184 participants
